COCP vs MRVL · rev $105.0K vs P/E 100, rev $5.16B
Cocrystal Pharma Inc (COCP) versus Marvell Technology Group Ltd (MRVL) — a side-by-side from cached financials, not a winner call.
Cocrystal Pharma Inc (COCP) is a biotechnology company listed on US.
Marvell Technology Group Ltd (MRVL) is a semiconductors company listed on NASDAQ. It is led by Matthew J. Murphy.
Latest reported COCP revenue for 2026-06-30 was $105.0K. Net income was -$3.2M. Revenue was down 53.3% from 2026-03-31 to 2026-06-30. COCP currently screens at market cap $13.3M.
Latest reported MRVL revenue for 2026-08-01 was $5.16B. Net income was $342.5M. MRVL currently screens at market cap $253.51B and trailing P/E 99.8.
COCP currently screens at market cap $13.3M. MRVL currently screens at market cap $253.51B and trailing P/E 99.8.
Not investment advice. Open the COCP and MRVL stock pages for the full models.
Not investment advice.